Noggin hFc Chimera, Mouse
Noggin HFc Chimera, Mouse

Measured by its ability to inhibit BMP-4-induced alkaline phosphataseproduction by ATDC5 mouse chondrogenic cells. The ED for this effect is 10 - 80 ng/ml in the presence of 50 ng/mL of Recombinant Human BMP-4.

Noggin HFc Chimera, Mouse

The purity of Noggin hFc Chimera, Mouse is greater than 90% as determined by SEC-HPLC.

Noggin HFc Chimera, Mouse

Noggin hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 90%.

Noggin hFc Chimera, Mouse

Noggin is an antagonist of bone morphogenetic proteins (BMP), being indispensable for certain developmental events.Noggin expression positively correlated with EGFR expression in both GC cell line models and The Cancer Genome Atlas human GC cohort. Targeting EGFR and its downstream pathways diminished cell proliferation which was promoted by Noggin. Noggin promotes the proliferation of GC cells by upregulating EGFR and enhancing a vicious circle formed by β‑catenin, EGFR, ERK and Akt.
Z06283
¥63,425.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
Noggin (Gln28-Cys232)_x000D_
Accession # P97466		 hFc
N-term C-term
Purity > 90% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 49.83 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 55-65 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • Noggin HFc Chimera, Mouse
    • Noggin HFc Chimera, Mouse

    Measured by its ability to inhibit BMP-4-induced alkaline phosphataseproduction by ATDC5 mouse chondrogenic cells. The ED for this effect is 10 - 80 ng/ml in the presence of 50 ng/mL of Recombinant Human BMP-4.

  • Noggin HFc Chimera, Mouse
    • Noggin HFc Chimera, Mouse

    The purity of Noggin hFc Chimera, Mouse is greater than 90% as determined by SEC-HPLC.

  • Noggin HFc Chimera, Mouse
    • Noggin HFc Chimera, Mouse

    Noggin hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 90%.


Background
Target Background Noggin is an antagonist of bone morphogenetic proteins (BMP), being indispensable for certain developmental events.Noggin expression positively correlated with EGFR expression in both GC cell line models and The Cancer Genome Atlas human GC cohort. Targeting EGFR and its downstream pathways diminished cell proliferation which was promoted by Noggin. Noggin promotes the proliferation of GC cells by upregulating EGFR and enhancing a vicious circle formed by β‑catenin, EGFR, ERK and Akt.
Synonyms Noggin; NOG; SYM1; SYNS1

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.